The peroxisome proliferator-activated receptor γ coactivator-1 alpha rs8192678 (Gly482Ser) variant and hepatitis B virus clearance

References

• WHO. Hepatitis B key facts. Available https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. (Accessed on 31 August 2022)
   Google Scholar
• Abounouh K, Aitraise I, Benabou A, et al. Virus-associated human cancers in Moroccan population: from epidemiology to prospective research. Infect Genet Evol. 2019;75:103990. doi: 10.1016/j.meegid.2019.103990.
   PubMed Web of Science ®Google Scholar
• Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582–592. doi: 10.1016/S0140-6736(09)60207-5.
   PubMed Web of Science ®Google Scholar
• Ma Y, et al. Antiviral compounds screening targeting HBx protein of the hepatitis B virus. Int J Mol Sci. 2022;23(19):12015. doi: 10.3390/ijms231912015.
   Web of Science ®Google Scholar
• Ezzikouri S, Pineau P, Benjelloun S. Hepatitis B virus in the Maghreb region: from epidemiology to prospective research. Liver Int. 2013;33(6):811–819. doi: 10.1111/liv.12135.
   PubMed Web of Science ®Google Scholar
• Allweiss L, Strick-Marchand H. In-vitro and in-vivo models for hepatitis B cure research. Curr Opin HIV AIDS. 2020;15(3):173–179. doi: 10.1097/COH.0000000000000616.
   PubMed Web of Science ®Google Scholar
• Tang H, McLachlan A. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci U S A. 2001;98(4):1841–1846. doi: 10.1073/pnas.041479698.
   PubMed Web of Science ®Google Scholar
• Reese VC, Oropeza CE, McLachlan A. Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids. J Virol. 2013;87(2):991–997. doi: 10.1128/JVI.01562-12.
   PubMed Web of Science ®Google Scholar
• Reese V, Ondracek C, Rushing C, et al. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int J Biochem Cell Biol. 2011;43(2):230–237. doi: 10.1016/j.biocel.2009.11.016.
   PubMed Web of Science ®Google Scholar
• Newbold JE, Xin H, Tencza M, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol. 1995;69(6):3350–3357. doi: 10.1128/JVI.69.6.3350-3357.1995.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300(5622):1140–1142. doi: 10.1126/science.1082889.
   PubMed Web of Science ®Google Scholar
• Choi YS, Hong JM, Lim S, et al. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. Biochem Biophys Res Commun. 2006;344(3):708–712. doi: 10.1016/j.bbrc.2006.03.193.
   PubMed Web of Science ®Google Scholar
• Liu C, Lin JD. PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin. 2011;43(4):248–257. doi: 10.1093/abbs/gmr007.
   Google Scholar
• Rhee J, Inoue Y, Yoon JC, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A. 2003;100(7):4012–4017. doi: 10.1073/pnas.0730870100.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Wu Z, Park CW, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92(6):829–839. doi: 10.1016/s0092-8674(00)81410-5.
   PubMed Web of Science ®Google Scholar
• Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol.2000;20(5):1868–1876. doi: 10.1128/MCB.20.5.1868-1876.2000.
   PubMed Web of Science ®Google Scholar
• Knutti D, Kaul A, Kralli A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol Cell Biol. 2000;20(7):2411–2422. doi: 10.1128/MCB.20.7.2411-2422.2000.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Castellani LW, Sinal CJ, et al. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 2004;18(2):157–169. doi: 10.1101/gad.1138104.
   PubMed Web of Science ®Google Scholar
• Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001;413(6852):131–138. doi: 10.1038/35093050.
   PubMed Web of Science ®Google Scholar
• Shlomai A, Paran N, Shaul Y. PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci U S A. 2006;103(43):16003–16008. doi: 10.1073/pnas.0607837103.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu W, Li X, et al. Association between PPARGC1A gene polymorphisms and coronary artery disease in a chinese population. Clin Exp Pharmacol Physiol. 2008;35(10):1172–1177. doi: 10.1111/j.1440-1681.2008.04988.x.
   PubMed Web of Science ®Google Scholar
• Vimaleswaran KS, Radha V, Ghosh S, et al. Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to type 2 diabetes in asian indians. Diabet Med. 2005;22(11):1516–1521. doi: 10.1111/j.1464-5491.2005.01709.x.
   PubMed Web of Science ®Google Scholar
• Muller YL, Bogardus C, Pedersen O, et al. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes. 2003;52(3):895–898. doi: 10.2337/diabetes.52.3.895.
   PubMed Web of Science ®Google Scholar
• Zhang K-H, Huang Q, Dai X-P, et al. Effects of the peroxisome proliferator activated receptor-gamma coactivator-1alpha (PGC-1alpha) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in chinese patients with type 2 diabetes mellitus. J Clin Pharmacol. 2010;50(9):1022–1030. doi: 10.1177/0091270009355159.
   PubMed Web of Science ®Google Scholar
• Villegas R, Williams SM, Gao Y-T, et al. Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes. Ann Hum Genet. 2014;78(1):23–32. doi: 10.1111/ahg.12044.
   PubMed Web of Science ®Google Scholar
• Zhang RN, Shen F, Pan Q, et al. PPARGC1A rs8192678 G > a polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2021;27(25):3863–3876. doi: 10.3748/wjg.v27.i25.3863.
   PubMed Web of Science ®Google Scholar
• European L. Association for the study of the, EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–185. doi: 10.1016/j.jhep.2012.02.010.
   PubMed Web of Science ®Google Scholar
• Ezzikouri S, Essaid El Feydi A, Afifi R, et al. Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma. Int J Biol Markers. 2011;26(4):229–233. Oct-Dec doi: 10.5301/JBM.2011.8881.
   PubMed Web of Science ®Google Scholar
• Kwon H, Lok AS. Hepatitis B therapy. Nat Rev Gastroenterol Hepatol. 2011;8(5):275–284. doi: 10.1038/nrgastro.2011.33.
   PubMed Web of Science ®Google Scholar
• Hayes N, Chayama K. Unmet needs in basic research of hepatitis B virus infection. In Vitro and in vivo models, in hepatitis B virus and liver disease. Singapore: Springer; 2021. p. 29–49
   Google Scholar
• Xia Y, Cheng X, Li Y, et al. Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype. J Virol. 2018;92(19): e00722–18 doi: 10.1128/JVI.00722-18.
   PubMed Web of Science ®Google Scholar
• Chong C-L, Chen M-L, Wu Y-C, et al. Dynamics of HBV cccDNA expression and transcription in different cell growth phase. J Biomed Sci. 2011;18(1):96. doi: 10.1186/1423-0127-18-96.
   PubMedGoogle Scholar
• Wu H, Deng X, Shi Y, et al. PGC-1alpha, glucose metabolism and type 2 diabetes mellitus. J Endocrinol. 2016;229(3):R99–R115. doi: 10.1530/JOE-16-0021.
   PubMed Web of Science ®Google Scholar
• Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006;27(7):728–735. doi: 10.1210/er.2006-0037.
   PubMed Web of Science ®Google Scholar
• Vohl MC, Houde A, Lebel S, et al. Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome. Mol Genet Metab. 2005;86(1-2):300–306. doi: 10.1016/j.ymgme.2005.07.002.
   PubMed Web of Science ®Google Scholar
• Leone TC, Lehman JJ, Finck BN, et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLOS Biol. 2005;3(4):e101. p. doi: 10.1371/journal.pbio.0030101.
   PubMed Web of Science ®Google Scholar
• Arya R, Duggirala R, Jenkinson CP, et al. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. Am J Hum Genet. 2004;74(2):272–282. doi: 10.1086/381717.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Oberkofler H, Linnemayr V, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes. 2002;51(4):1281–1286. doi: 10.2337/diabetes.51.4.1281.
   PubMed Web of Science ®Google Scholar
• Andrulionyte L, Peltola P, Chiasson JL, et al. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes. 2006;55(7):2148–2152. doi: 10.2337/db05-1629.
   PubMed Web of Science ®Google Scholar
• Li X, Pan E, Zhu J, et al. Cisplatin enhances hepatitis B virus replication and PGC-1alpha expression through endoplasmic reticulum stress. Sci Rep. 2018;8(1):3496. doi: 10.1038/s41598-018-21847-3.
   PubMedGoogle Scholar
• Rechtman MM, Har-Noy O, Bar-Yishay I, et al. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett. 2010;584(11):2485–2490. doi: 10.1016/j.febslet.2010.04.067.
   PubMed Web of Science ®Google Scholar
• D. N. Gross, A. P. van den Heuvel, and M. J. Birnbaum, The role of FoxO in the regulation of metabolism. Oncogene. 2008;27(16):2320–2336., doi: 10.1038/onc.2008.25.
   PubMed Web of Science ®Google Scholar
• Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res. [Online]. 2002;43(1):2–12. https://www.ncbi.nlm.nih.gov/pubmed/11792716. doi: 10.1016/S0022-2275(20)30180-2.
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 2000;102(6):731–744. doi: 10.1016/s0092-8674(00)00062-3.
   PubMed Web of Science ®Google Scholar
• Mitchell SM, Frayling TM. The role of transcription factors in maturity-onset diabetes of the young. Mol Genet Metab. 2002;77(1–2):35–43. doi: 10.1016/s1096-7192(02)00150-6.
   PubMed Web of Science ®Google Scholar
• Estall JL, Kahn M, Cooper MP, et al. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression. Diabetes. 2009;58(7):1499–1508. doi: 10.2337/db08-1571.
   PubMed Web of Science ®Google Scholar
• Ramiere C, et al. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. J Virol. 2008;82(21):10832–10840. doi: 10.1128/JVI.00883-08.
   PubMed Web of Science ®Google Scholar
• Kim HY, Cho HK, Choi YH, et al. Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity. Febs J. 2010;277(13):2791–2802. doi: 10.1111/j.1742-4658.2010.07695.x.
   PubMed Web of Science ®Google Scholar
• Yan L-B, Liao J, Han N, et al. Association between hepatitis B virus infection and metabolic Syndrome in Southwest China: a cross-sectional study. Sci Rep. 2020;10(1):6738. doi: 10.1038/s41598-020-62609-4.
   PubMed Web of Science ®Google Scholar
• Oehler N, Volz T, Bhadra OD, et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology. 2014;60(5):1483–1493. doi: 10.1002/hep.27159.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wang Y, Ye LH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med. 2014;11(3):182–190. doi: 10.7497/j.issn.2095-3941.2014.03.004.
   PubMedGoogle Scholar
• Yan L-B, Yu Y-J, Zhang Q-B, et al. Identification of p90 ribosomal S6 kinase 2 as a novel host protein in HBx augmenting HBV replication by iTRAQ-based quantitative comparative proteomics. Proteomics Clin Appl. 2018;12(3):e1700090. p. doi: 10.1002/prca.201700090.
   PubMed Web of Science ®Google Scholar
• Kim KH, Shin H-J, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology. 2007;132(5):1955–1967. doi: 10.1053/j.gastro.2007.03.039.
   PubMed Web of Science ®Google Scholar
• Kim KH, Hong SP, Kim K, et al. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun. 2007;355(4):883–888. doi: 10.1016/j.bbrc.2007.02.044.
   PubMed Web of Science ®Google Scholar
• Kang SK, Chung TW, Lee JY, et al. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem. 2004;279(27):28106–28112. doi: 10.1074/jbc.M403176200.
   PubMed Web of Science ®Google Scholar
• Larter CZ, Farrell GC. Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat? J Hepatol. 2006;44(2):253–261. doi: 10.1016/j.jhep.2005.11.030.
   PubMed Web of Science ®Google Scholar
• Curtil C, Enache LS, Radreau P, et al. The metabolic sensors FXRalpha, PGC-1alpha, and SIRT1 cooperatively regulate hepatitis B virus transcription. Faseb J.2014;28(3):1454–1463. doi: 10.1096/fj.13-236372.
   PubMed Web of Science ®Google Scholar
• Weng S-W, Lin T-K, Wang P-W, et al. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity. Metabolism. 2010;59(4):581–586. doi: 10.1016/j.metabol.2009.08.021.
   PubMed Web of Science ®Google Scholar
• Vázquez-Del Mercado M, Guzmán-Ornelas M-O, Corona Meraz F-I, et al. The 482Ser of PPARGC1A and 12Pro of PPARG2 alleles are associated with reduction of metabolic risk factors even obesity in a Mexican-Mestizo population. Biomed Res Int. 2015;2015:1–14. doi: 10.1155/2015/285491.
   Web of Science ®Google Scholar
• Sasaki T, Takahashi Y, Yoshinaga K, et al. An association between human parvovirus B-19 infection and autoantibody production. J Rheumatol. [Online]. Available: 1989;16(5):708–709. https://www.ncbi.nlm.nih.gov/pubmed/2547062.
   PubMed Web of Science ®Google Scholar
• Chen Y, Mu P, He S, et al. Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor gamma coactivator-1alpha on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes. Nutr Res. 2013;33(4):332–339. doi: 10.1016/j.nutres.2013.02.003.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis. 2012;32(1):3–13. doi: 10.1055/s-0032-1306421.
   PubMed Web of Science ®Google Scholar
• Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100(14):8466–8471. doi: 10.1073/pnas.1032913100.
   PubMed Web of Science ®Google Scholar
• Tai C-M, Huang C-K, Tu H-P, et al. Interactions of a PPARGC1A variant and a PNPLA3 variant affect nonalcoholic steatohepatitis in severely obese taiwanese patients. Medicine. 2016;95(12):e3120. doi: 10.1097/MD.0000000000003120.
   PubMed Web of Science ®Google Scholar
• Zhao X, Shah D, Sambamoorthi U. Association between chronic hepatitis B infection and metabolic syndrome. J Diabetes Metab Disord. 2018;17(2):223–232. doi: 10.1007/s40200-018-0364-4.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Bennet L, Ridderstrale M, et al. The PPARGC1A Gly482Ser polymorphism is associated with left ventricular diastolic dysfunction in men. BMC Cardiovasc Disord. 2008;8:37. doi: 10.1186/1471-2261-8-37.
   PubMed Web of Science ®Google Scholar
• Cheurfa N, Reis AF, Dubois-Laforgue D, et al. The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men. Diabetologia. 2004;47(11):1980–1983. doi: 10.1007/s00125-004-1567-4.
   PubMed Web of Science ®Google Scholar
• Okauchi Y, Iwahashi H, Okita K, et al. PGC-1alpha Gly482Ser polymorphism is associated with the plasma adiponectin level in type 2 diabetic men. Endocr J. 2008;55(6):991–997. doi: 10.1507/endocrj.k08e-070.
   PubMed Web of Science ®Google Scholar
• Handschin C, Rhee J, Lin J, et al. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A. 2003;100(12):7111–7116. doi: 10.1073/pnas.1232352100.
   PubMed Web of Science ®Google Scholar
• Kim DH, Kang HS, Kim KH. Roles of hepatocyte nuclear factors in hepatitis B virus infection. World J Gastroenterol. 2016;22(31):7017–7029. pp. Aug 21 doi: 10.3748/wjg.v22.i31.7017.
   PubMed Web of Science ®Google Scholar
• Shi Y, Li Y, Huang C, et al. Resveratrol enhances HBV replication through activating Sirt1-PGC-1alpha-PPARalpha pathway. Sci Rep. 2016;6:24744. doi: 10.1038/srep24744.
   PubMed Web of Science ®Google Scholar
• Csep K, Szigeti E, Vitai M, et al. The Ppargc1a - Gly482ser polymorphism (Rs8192678) and the metabolic syndrome in a Central romanian population. Acta Endocrinol. 2017;13(2):161–167. pp. Apr-Jun doi: 10.4183/aeb.2017.161.
   Google Scholar
• Besse-Patin A, Leveille M, Oropeza D, et al. Estrogen signals through peroxisome Proliferator-Activated receptor-gamma coactivator 1alpha to reduce oxidative damage associated with diet-induced fatty liver disease. Gastroenterology. Jan 2017;152(1):243–256. pp. doi: 10.1053/j.gastro.2016.09.017.
   PubMed Web of Science ®Google Scholar
• Nitz I, Ewert A, Klapper M, et al. Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function. Biochem Biophys Res Commun. 2007;353(2):481–486. doi: 10.1016/j.bbrc.2006.12.042.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Gerhart-Hines Z, et al. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 2008;582(1):46–53. doi: 10.1016/j.febslet.2007.11.034.
   PubMed Web of Science ®Google Scholar
• Fanelli M, Filippi E, Sentinelli F, et al. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects. Dis Markers. 2005;21(4):175–180. doi: 10.1155/2005/576748.
   PubMed Web of Science ®Google Scholar
• Cunningham F, Allen JE, Allen J, et al. Ensembl 2022. Nucleic Acids Res. 2022;50(D1):D988–D995. doi: 10.1093/nar/gkab1049.
   PubMed Web of Science ®Google Scholar
• de Bakker PI, Yelensky R, Pe’er I, et al. Efficiency and power in genetic association studies. Nat Genet. 2005;37(11):1217–1223 doi: 10.1038/ng1669.
   PubMed Web of Science ®Google Scholar